Join the club for FREE to access the whole archive and other member benefits.

KIZOO Technology Ventures

Company providing financing and its focus is on rejuvenation biotech

KIZOO provides mentoring, seed and follow-on financing with a focus on rejuvenation biotech. 

Having been entrepreneurs, VCs and mentors in both, high growth tech and biotech companies theirselves for many years with multiple exits and massive value created for the founders, they now bring this experience to the emerging field of rejuvenation 

biotech - a young industry that will eventually become much bigger than today's largest technology markets.​As part of the Forever Healthy Group, they directly support the creation of startups that turn research on the root causes of aging into therapies and services for humans.​Forever Healthy's other initiatives include the evaluation of new rejuvenation therapies, evidenced-based curation of the world's cutting-edge medical knowledge, funding research projects on the root causes of aging and hosting the annual Undoing Aging Conference.

Visit website: https://www.kizoo.com/en.html

 KizooVentures

 kizoo

 Kizoo

Details last updated 04-May-2019

People at KIZOO Technology Ventures

Frank Schueler

Managing Director of Kizoo Technology Capital

Patrick Burgermeister

Molecular biologist, investor and futurist.

KIZOO Technology Ventures News

cellvie closes $5.5 million of financing to develop its allogeneic mitochondria therapies

cellvie closes $5.5 million of financing to develop its allogeneic mitochondria therapies

KIZOO Technology Ventures - 06-Feb-2023

Mitochondria dysfunction is linked to several ageing-related diseases, including neurodegeneration, so a big potential market

Stem cell biotech MoglinBio secures seed investment

Stem cell biotech MoglinBio secures seed investment

KIZOO Technology Ventures - 26-Oct-2022

Kizoo is focused on rejuvenation biotech so it must see potential in normalizing CDC42 activity

Longevity Technology interviews cellvie CEO, Alex Schueller, about therapeutic mitochondria

Longevity Technology interviews cellvie CEO, Alex Schueller, about therapeutic mitochondria

Longevity Technology - 14-Sep-2022

Initially targeting ischemia-reperfusion injury, TMT has potential to treat multiple age-related diseases

Elastrin Therapeutics secures $10 million of funding for its calcification removal platform

Elastrin Therapeutics secures $10 million of funding for its calcification removal platform

Forever Healthy Foundation - 07-Apr-2022

Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications

Underdog pharmaceuticals secures $10m funding from Kizoo ventures

Underdog pharmaceuticals secures $10m funding from Kizoo ventures

Longevity Technology - 23-Sep-2021

Funds to bring affordable and effective age-related therapies to the public

Michael Greve promises 300m euros to advance rejuvenation startups

Michael Greve promises 300m euros to advance rejuvenation startups

Longevity Technology - 06-May-2021

Kizoo Technology Ventures helps to bring rejuvenation therapies from lab to clinic